Priya Uppal
South Miami, FLNPI 1730883216
Payments from drug & device makers
Across 127 payments — averaging $39.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$788
- Incyte Corporation$559
- Sanofi$474
- UCB, Inc.$394
- Galderma Laboratories, L.p.$394
- Arcutis Biotherapeutics, Inc.$371
- plus $2K from 13 others
What the payments were for
- Food & beverage$4,77095%
- Education$2715%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 29 | $788 |
| Incyte Corporation | 14 | $559 |
| Sanofi | 13 | $474 |
| UCB, Inc. | 8 | $394 |
| Galderma Laboratories, L.p. | 6 | $394 |
| Arcutis Biotherapeutics, Inc. | 18 | $371 |
| E.r. Squibb & Sons, L.L.C. | 3 | $349 |
| Amgen | 5 | $331 |
| Johnson & Johnson | 3 | $250 |
| Novartis | 11 | $219 |
| Lilly USA, LLC | 6 | $212 |
| Sanofi-aventis U.S. LLC | 2 | $171 |
| Pfizer | 1 | $121 |
| Verrica Pharmaceuticals Inc. | 1 | $121 |
| Janssen Scientific Affairs, LLC | 1 | $113 |
| Boehringer Ingelheim | 3 | $82 |
| Organogenesis Inc. | 1 | $41 |
| Kyowa Kirin, Inc. | 1 | $28 |
| Biofrontera Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.